 |
|
Cytokines and Type 2 Diabetes Mellitus
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
To the Editor: Dr Pradhan and colleagues1 found that elevated levels of interleukin 6 (IL-6) were associated with the risk of developing type 2 diabetes mellitus in a large cohort of apparently healthy middle-aged women. Their data are consistent with the results of others.2-3 According to Pradhan et al, type 2 diabetes mellitus may be a manifestation of a long lasting and ongoing cytokine-mediated acute phase response involving IL-6. However, the mechanisms of the diabetogenic action of IL-6 are far from clear. Modulation of insulin secretion by IL-6 does not seem to be a major factor; on the other hand, there is recent evidence that IL-6 may produce insulin resistance.2-3 Cytokines can exert their effects either directly or indirectly, although a direct effect of IL-6 on the insulin–receptor transduction pathway has not been demonstrated. Indirect effects on insulin resistance have been attributed to the stimulatory action of IL-6 on the . . . [Full Text of this Article]
RELATED ARTICLE
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Aruna D. Pradhan, JoAnn E. Manson, Nader Rifai, Julie E. Buring, and Paul M. Ridker
JAMA. 2001;286(3):327-334.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Hepatosplanchnic clearance of interleukin-6 in humans during exercise
Febbraio et al.
Am. J. Physiol. Endocrinol. Metab. 2003;285:E397-E402.
ABSTRACT
| FULL TEXT
Type 2 diabetes as an inflammatory disorder
Sattar et al.
British Journal of Diabetes & Vascular Disease 2003;3:36-41.
ABSTRACT
Is Metabolic Syndrome X an Inflammatory Condition?
Das
Exp. Biol. Med. 2002;227:989-997.
ABSTRACT
| FULL TEXT
Muscle-derived interleukin-6: mechanisms for activation and possible biological roles
FEBBRAIO and PEDERSEN
FASEB J. 2002;16:1335-1347.
ABSTRACT
| FULL TEXT
|
